摘要
本文梳理了2020年中美两国批准上市的新型冠状病毒肺炎(COVID-19)体外诊断产品情况,对比分析了两国产品在上市趋势、来源、类别、检测样本、检测靶标和检测方法方面的异同,并据此展望了COVID-19体外诊断技术未来的发展方向,旨在为我国体外诊断产品的发展提供有益参考。
This paper reviews COVID-19 in vitro diagnosis products approved by China and the United States in 2020,analyzes the similarities and differences between the two countries in marketing trends,sources,categories,test samples,detection targets and detection methods,and looks forward to the future development direction of COVID-19 in vitro diagnosis technology.The purpose of this paper is to provide a useful reference for the development of epidemic prevention and control and in vitro diagnosis in China.
作者
王燕妮
张泽波
WANG Yanni;ZHANG Zebo(Taizhou Institute for Drug Control,Taizhou,Jiangsu 225300,China;Taizhou Pharmaceutical Technology Transfer Center,Taizhou,Jiangsu 225300,China)
出处
《国际检验医学杂志》
CAS
2021年第S01期200-206,共7页
International Journal of Laboratory Medicine
关键词
COVID-19体外诊断产品
新型冠状病毒
中美对比
核酸检测
抗原抗体检测
COVID-19 In vitro diagnostic products
2019-nCoV
comparison between China and USA
nucleic acid detection
antigen test and serological detection